DHT Blockers and Hair Loss: What the Research Actually Shows

What you need to know before trying a DHT blocker

Important notice: This article is for general educational purposes only. It is not medical advice, and it is not a substitute for a diagnosis or treatment plan from a licensed physician or healthcare provider. Every person’s situation is different. Do not start, stop, or change any treatment based on what you read here. If you are experiencing hair loss, please consult a qualified medical professional before trying any treatment.

If you have been researching hair loss, you have probably come across the term “DHT blocker.” These products and medications are widely discussed, but what does the science actually say about how well they work, who DHT blockers for hair loss are right for, and what the risks look like? Here is a plain-language look at the published evidence.

First, what is DHT and why does it matter?

DHT stands for dihydrotestosterone. It is a hormone that the body produces naturally by converting testosterone using an enzyme called 5-alpha reductase. Both men and women produce DHT, and in most people it causes no problems at all. But in people who are genetically predisposed to pattern hair loss, the hair follicles on certain areas of the scalp are unusually sensitive to DHT.^[1]

When DHT attaches to those sensitive follicles, it gradually shrinks them over time. Each hair grows back a little thinner and shorter than the last. Eventually, if the process continues without treatment, the follicle may stop producing visible hair altogether. This process is called follicular miniaturization, and it is the primary mechanism behind androgenetic alopecia, the clinical term for male and female pattern hair loss.^[2]

It is worth being clear about one thing: DHT itself is not a villain. It plays normal roles in the body. The issue is follicular sensitivity, which is largely determined by your genetics. Two people can have identical DHT levels, and one will lose hair while the other does not.

The treatments discussed in this article affect hormone levels and carry real risks that vary from person to person. Nothing here should be read as a recommendation to use any particular product or medication. Only a licensed doctor can determine what is appropriate for your individual situation.

What does a DHT blocker actually do for hair loss?

Despite the name, most DHT blockers for hair loss do not block DHT directly. They work by inhibiting the 5-alpha reductase enzyme, which is responsible for converting testosterone into DHT in the first place. Less conversion means lower DHT levels in the scalp, which in turn slows or stops the miniaturization process. The proper term for these agents is 5-alpha reductase inhibitors, often abbreviated as 5-ARIs.

How much DHT is reduced, and where in the body that reduction occurs, depends on which agent is used, how it is taken, and at what dose. These differences matter quite a bit clinically, which is one of the reasons that a one-size-fits-all approach to DHT blockers is not well supported by the evidence.

Prescription medications: what the clinical research shows

Oral finasteride

Finasteride at a dose of 1 mg per day has been approved by the U.S. Food and Drug Administration (FDA) for treating male pattern hair loss since 1997. Finasteride at a dose of 2.5mg-5mg orally has been used off-label for post menopausal woman & those with pcos to fight hair loss. It has been studied more extensively than any other treatment in this category. Clinical studies have found that it reduces DHT levels in the scalp and bloodstream by roughly 60 to 70 percent.^[3]

The original large-scale trials enrolled 1,553 men between the ages of 18 and 41. Compared to the placebo group, the men taking finasteride showed meaningful increases in hair count at both the one-year and two-year marks, while the placebo group continued to lose hair throughout the study period.^[4] A follow-up study tracked participants for five years and found that the benefits held up over the long term, as long as treatment continued. When men stopped taking the medication, DHT levels rose again and hair loss resumed.^[5] Finasteride has also shown statistically significant benefit in men aged 41 to 60 in separate trials.^[6]

This last point is important. Finasteride is not a cure. It manages the condition while it is being taken, and results are generally lost if someone stops using it.

Finasteride is FDA-approved for men only. It is absolutely contraindicated for women who are pregnant or who may become pregnant, because it has been shown to cause serious developmental abnormalities in male fetuses. Any discussion of finasteride use in women, including postmenopausal women where it is sometimes prescribed off-label, must happen under the direct supervision of a licensed physician.^[7]

Topical finasteride

Researchers have developed a topical version of finasteride applied directly to the scalp. The goal is to deliver the drug where it is needed while reducing the amount that enters the bloodstream, which in turn may lower the risk of systemic side effects.

A large phase III clinical trial found that the topical spray produced significantly greater hair count improvements than placebo at the 24-week mark, with results comparable to oral finasteride. The key finding was that blood concentration of the drug was more than 100 times lower with the topical version than with the oral pill.^[8] It is worth noting that topical finasteride is not currently FDA-approved in the United States. Its availability and legal status vary by country, and it requires a prescription from a licensed physician.

Dutasteride

Dutasteride is a more powerful cousin of finasteride. While finasteride targets one form of the 5-alpha reductase enzyme, dutasteride targets both forms. This gives it a broader reach, and studies have found it can reduce DHT levels by more than 90 percent.^[2]

A published meta-analysis reviewing 23 clinical trials found that dutasteride at 0.5 mg per day showed the highest probability of efficacy among the nonsurgical medication options studied, outperforming finasteride and oral minoxidil on average hair count improvement.^[9] However, dutasteride is not FDA-approved for hair loss in the United States. It is used off-label here, which means it can only be obtained through a physician who has evaluated your specific case and determined it is appropriate for you.

Natural options: what the evidence actually supports

A wide range of plant-based products are marketed as natural DHT blockers for hair loss. The two with the most human clinical data behind them are saw palmetto and pumpkin seed oil. Before reviewing the evidence, it is important to understand that dietary supplements are not reviewed or approved by the FDA for safety or effectiveness the way prescription medications are. Variability in product quality, dose, and formulation is significant, and results from one product may not apply to another.

Saw palmetto

Saw palmetto is an extract from the berries of a palm plant native to Florida. Laboratory studies have found that it can inhibit both forms of the 5-alpha reductase enzyme, though with considerably less potency than prescription medications.^[10]

A systematic review of seven clinical trials involving 381 patients found positive signals. Studies reported improvements in overall hair quality in 60 percent of participants, a 27 percent increase in total hair count, and increased density in 83 percent of patients using oral and topical saw palmetto formulations. The reviewers noted, however, that many of these trials combined saw palmetto with other active ingredients, which makes it difficult to know exactly how much of the benefit came from saw palmetto alone.^[10]

In a head-to-head comparison, 38 percent of patients taking saw palmetto at 320 mg per day for 24 months showed hair growth, compared to 68 percent of those taking finasteride. The researchers concluded that saw palmetto may provide modest benefit in mild to moderate pattern hair loss, but acknowledged the meaningfully lower response rate compared to the prescription option.^[11]

Pumpkin seed oil

The primary human trial for pumpkin seed oil was a randomized, double-blind, placebo-controlled study published in 2014. It enrolled 76 men with mild to moderate hair loss, who took either 400 mg of pumpkin seed oil or a placebo daily for 24 weeks. The group taking pumpkin seed oil saw a 40 percent improvement in hair count, compared to 10 percent in the placebo group. Researchers suggested possible 5-alpha reductase inhibition as a contributing mechanism, though they acknowledged this had not been fully confirmed in human tissue.^[12]

This is a promising result, but it comes from one study. Independent replication in larger trials has not yet been published, which means the evidence base for pumpkin seed oil remains limited compared to the prescription options.

DHT blockers for hair loss: comparing the options

Side effects: an honest look at the risks

Any responsible discussion of DHT-blocking medications has to address side effects directly. The following reflects what the published research reports, not a prediction of what any one person will experience.

In the original finasteride clinical trials, sexual side effects were reported more often in the treatment group than in the placebo group. Specifically, 4.2 percent of finasteride users reported sexual adverse events, compared to 2.2 percent of those taking placebo. These effects included reduced sex drive, lower ejaculate volume, and erectile dysfunction. Many patients in the studies saw these effects resolve even while continuing treatment.^[13]

A more contested topic in the medical literature is something called post-finasteride syndrome. A subset of men have reported persistent sexual and psychological symptoms that continued even after stopping the medication. The scientific debate around this condition is ongoing. Some peer-reviewed analyses have highlighted significant limitations in the studies that describe it, including the fact that patients who are told to expect sexual side effects report them at much higher rates than patients who are not told. One blinded trial found that 43.6 percent of informed patients reported sexual side effects, compared to 14.3 percent of uninformed patients.^[14]

What is not in dispute is this: the FDA has updated finasteride’s prescribing label to include the risk of persistent sexual dysfunction and depression, and regulatory agencies in the United Kingdom and Sweden have made similar updates to their patient information materials. The published medical literature recommends that people with a prior history of depression, sexual dysfunction, or fertility concerns have a careful, individualized conversation with their doctor before starting any 5-alpha reductase inhibitor.^[15]

For women, the most critical safety issue with oral finasteride is its potential to cause serious birth defects. It is absolutely off-limits for women who are or may become pregnant. Evidence for its effectiveness in women is also less robust than in men, which is another reason why the decision to use it requires careful medical guidance.^[7]

What DHT blockers cannot do

Several things get left out of most online discussions when discussing DHT blockers for hair loss, and they are worth knowing upfront.

These treatments are not a cure. They manage the condition while you take them. When you stop, DHT levels return to their previous state and hair loss tends to resume. The five-year finasteride trial data confirmed this clearly: the benefits reversed when patients stopped taking the medication.^[5] This is a long-term commitment, and that commitment has its own implications.

They work by helping to preserve follicles that are still functioning. They are not understood to restore follicles that have already been permanently lost. Getting started earlier in the hair loss process is generally considered by specialists to offer better results than starting after significant loss has already occurred.

Perhaps most importantly, not all hair loss is caused by DHT. Conditions like alopecia areata, alopecia universalis, alopecia totalis, CCCA or central centrifugal cicatricial alopecia, ophiasis alopecia, thyroid disorders, lupus, nutritional deficiencies, IDA or iron deficiency anemia, stress-related shedding or TE telegen effluvium, trichotillamania, and scalp-damaging hairstyles can all cause thinning that looks similar to pattern hair loss on the surface. Using a DHT blocker for one of these conditions would not help, and could delay finding the real cause. This is exactly why a proper diagnosis from a qualified professional matters before any treatment begins.

The most important step is also the simplest one. Hair loss is a deeply personal experience, and it is not a one-size-fits-all condition. The right approach depends on the type and stage of your hair loss, your overall health history, and factors that only a clinical evaluation can reveal. A qualified hair loss specialist can use tools like digital scalp analysis to assess what is actually happening at the follicle level, and to help you understand which options, if any, are appropriate for your situation. Finding a trustworthy, licensed professional is the most responsible first step you can take.

References

1. Panchaprateep R, Lueangarun S. “Androgenetic Alopecia: Therapy Update.” Int J Mol Sci / PMC. 2023. pmc.ncbi.nlm.nih.gov
2. Nestor MS, et al. “Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review.” PMC / NIH. 2023. pmc.ncbi.nlm.nih.gov
3. DermNet NZ. “Finasteride.” 2024. dermnetnz.org
4. Kaufman KD, et al. “Finasteride in the treatment of men with androgenetic alopecia.” J Am Acad Dermatol. 1998. PMID: 9777765. pubmed.ncbi.nlm.nih.gov
5. Kaufman KD, et al. “Long-term (5-year) multinational experience with finasteride 1 mg.” Eur J Dermatol. 2002. PMID: 11809594. pubmed.ncbi.nlm.nih.gov
6. Leyden J, et al. “Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60.” J Am Acad Dermatol. 2003. PMID: 12695131. pubmed.ncbi.nlm.nih.gov
7. Yim E, et al. “Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss.” Drug Des Devel Ther / PMC. 2020. pmc.ncbi.nlm.nih.gov
8. Esteban-Lucia L, et al. “Efficacy and safety of topical finasteride spray solution for male AGA: phase III RCT.” J Eur Acad Dermatol Venereol / PMC. 2022. pmc.ncbi.nlm.nih.gov
9. Lee S, et al. “Updates in Treatment for Androgenetic Alopecia.” Ann Dermatol. 2025. anndermatol.org
10. Evron E, et al. “Natural Hair Supplement: Friend or Foe? Saw Palmetto, a Systematic Review in Alopecia.” Skin Appendage Disord / PMC. 2020. pmc.ncbi.nlm.nih.gov
11. Dhurat R, et al. “Treatment options for androgenetic alopecia: Efficacy, side effects, compliance.” Dermatol Ther / PMC. 2022. pmc.ncbi.nlm.nih.gov
12. Cho YH, et al. “Effect of Pumpkin Seed Oil on Hair Growth in Men with AGA: RCT.” Evid Based Complement Alternat Med / PMC. 2014. pmc.ncbi.nlm.nih.gov
13. Irwig MS, Kolukula S. “Persistent Sexual Side Effects of Finasteride for Male Pattern Hair Loss.” J Sex Med. 2011. PMID: 21418145. sciencedirect.com
14. Singh MK, Avram M. “Persistent Sexual Dysfunction and Depression in Finasteride Users.” J Clin Aesthet Dermatol / PMC. 2014. pmc.ncbi.nlm.nih.gov
15. Pereira AFJR, Coelho TOA. “Post-finasteride syndrome.” An Bras Dermatol / PMC. 2020. pmc.ncbi.nlm.nih.gov

---

MEDICAL DISCLAIMER: The information provided in this and other blog posts on this website is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this blog.

This blog may contain links to third-party websites. These links are provided for convenience and informational purposes only and do not constitute an endorsement of the content, products, or services offered on those websites. While every effort is made to ensure the accuracy of the information presented, we make no guarantees regarding its completeness, accuracy, timeliness or fitness for a particular purpose. Reliance on any information provided in this blog is solely at your own risk. If you think you may have a medical emergency, call your doctor or emergency services immediately.

Reviewed by Leslie Robinson, Owner and Clinic Director, Mane Image, with 35 years of clinical experience in hair loss restoration.